Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is to assess tenofovir (TFV) PK and PD endpoints, cervicovaginal safety
parameters, susceptibility to HIV-1 infection, and objective measures of vaginal applicator
use in premenopausal and postmenopausal women.